Low-Dose Colchicine for Radiation Therapy Side Effects

This trial examines whether low-dose colchicine, a medication, can prevent or reduce skin problems caused by radiation treatment, such as burning or discoloration. It targets individuals with head and neck cancer undergoing radiation therapy. Participants will receive either a colchicine pill or a placebo daily. Suitable candidates include those diagnosed with specific types of head and neck cancer, planning to undergo radiation treatment, and not currently taking colchicine for other conditions. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this treatment.

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking colchicine or certain other medications like high doses of non-steroidal anti-inflammatory drugs or radiosensitizing agents.

Research has shown that colchicine is generally safe for humans. In one study, no patients experienced severe side effects from colchicine, with most reporting only mild skin issues, if any. Another source notes that colchicine is already used to treat inflammation and pain, indicating its well-established safety for these conditions.

However, like many medications, colchicine can cause side effects. Common ones include stomach pain, nausea, and diarrhea. Serious side effects are rare but may involve blood problems, such as low blood cell counts.

Most treatments for radiation therapy side effects focus on managing symptoms with anti-inflammatory drugs, pain relievers, or topical creams. However, colchicine is unique because it's being explored as an oral medication that might reduce inflammation at a cellular level. Unlike standard treatments, colchicine works by targeting the body's inflammatory response, potentially minimizing side effects from radiation more effectively. Researchers are excited about colchicine because it could offer a new way to tackle inflammation without the need for more invasive or topical interventions. This approach could lead to better overall comfort and outcomes for patients undergoing radiation therapy.

This trial will compare low-dose colchicine with a placebo to assess its effectiveness in managing side effects from radiation therapy. Research has suggested that colchicine might help by reducing swelling and protecting tissues from damage. One study found that colchicine shielded blood vessels from harm caused by radiation. Other research showed that colchicine lessened skin problems related to radiation treatment, with most patients experiencing only mild skin changes. While more research is needed, these early findings suggest colchicine could be a promising option for managing skin issues during radiation.¹³⁶⁷⁸